05:01 AM EDT, 07/30/2025 (MT Newswires) -- GSK (GSK) reported Q2 core earnings Wednesday of 46.5 pence ($0.62) per diluted share, up from 43.4 pence a year earlier.

Analysts polled by FactSet expected $0.59.

Revenue for the quarter ended June 30 was 7.99 billion pounds, up from 7.88 billion pounds a year earlier.

Analysts surveyed by FactSet expected 10.37 billion pounds.

The company now expects 2025 core EPS to increase toward the top end of its forecast range of 6% to 8%, compared with previous guidance for an increase between 6% and 8%.

Analysts surveyed by FactSet expect EPS of 2.19 pounds after adjusting for extraordinary items.

Meanwhile, full-year turnover is now projected to increase toward the top end of its forecast range of 3% to 5%, compared with its previous projections for an increase of between 3% and 5%.

Analysts polled by FactSet expect 42.58 billion pounds.